---
title: "NANFANG MEDICAL: It is expected that the net profit attributable to the owners of the parent company in the first half of the year will be a loss of 12 million to 16 million yuan, turning from profit to loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248445863.md"
description: "NANFANG MEDICAL expects a net loss attributable to the parent company owners of between 12 million and 16 million yuan in the first half of 2025, compared to a profit of 1.0265 million yuan in the same period last year, indicating a shift from profit to loss. During the reporting period, the prices of raw materials for some products increased, leading to higher costs. Additionally, factors such as international trade policies, geopolitical issues, and logistics transportation affected some product orders, significantly impacting revenue and profit"
datetime: "2025-07-14T13:20:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248445863.md)
  - [en](https://longbridge.com/en/news/248445863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248445863.md)
generator: "portal-rs"
---

# NANFANG MEDICAL: It is expected that the net profit attributable to the owners of the parent company in the first half of the year will be a loss of 12 million to 16 million yuan, turning from profit to loss year-on-year

NANFANG MEDICAL disclosed its performance forecast on the evening of July 14, expecting a net profit attributable to the owners of the parent company in the first half of 2025 to be between -12 million and -16 million yuan, compared to a net profit of 1.0265 million yuan in the same period last year, turning from profit to loss year-on-year. During the reporting period, the prices of raw materials for some of the company's products increased, leading to higher costs. Factors such as international trade policies, geopolitical issues, and logistics transportation have restricted some product orders, significantly impacting revenue and profit

### Related Stocks

- [603880.CN](https://longbridge.com/en/quote/603880.CN.md)

## Related News & Research

- [Sanlam subsidiary director T Fick sells shares worth R 610,755.60](https://longbridge.com/en/news/299061762.md)
- [Dogtopia Foundation Commemorates National Service Dog Month, Surpassing $5.6 Million Raised to Help Support More Than 820 Veteran-Service Dog Teams](https://longbridge.com/en/news/299068795.md)
- [10 Years of Growth and Innovation at Almac Pharma Services’ Charnwood](https://longbridge.com/en/news/299034116.md)
- [WeChat tests AI processing tools for image editing and information extraction](https://longbridge.com/en/news/298871844.md)
- [Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer](https://longbridge.com/en/news/298830338.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**